If you took the time to read over this board you should first take the time to read over the company's web site and find out what is it that they own before making statements that include BK as an option. They own at least $60 million after debt together with a drug delivery system which has been researched and is safe to use. The phase 3 study of their drug did not satisfied the end points, maybe because it was a faulty study since phase 2 had no troubles. Start from there.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.